 |
 |
|
|
News
- Reducing the Odds of Breast Cancer
- Molecular abnormalities almost double risk of recurrence, researchers find
TUESDAY, May 11 (HealthDayNews) -- Doctors have found a molecular indicator in breast cancer tumor cells that could become a reliable way of predicting whether cancer will recur in a patient.
A specific pattern of molecular abnormalities in the cells appears to almost double the risk of a patient suffering cancer again, says a study published in the May issue of Clinical Cancer Research.
The study involved the examination of a decade's worth of tumor samples, collected from patients who underwent cancer surgery between 1990 and 2001.
The researchers hope that by finding a way to predict the long-term risk of cancer recurrence, they will reduce the number of women who have to go through adjuvant chemotherapy. Adjuvant therapy is a follow-up measure done after the main procedure to make sure all microscopic traces of cancer in the body are eradicated.
"The ability to identify patients who are at such a low risk of recurrence that they can safely forego the discomfort and potential complications of adjuvant therapy would be a major breakthrough," study co-author Dr. Thomas Julian, associate director of the Breast Care Center at Allegheny General Hospital in Pittsburgh, said in a prepared statement.
More information
The National Institutes of Health have more about adjuvant chemotherapy.
- --Dennis Thompson
- SOURCES: West Penn Allegheny Health System, news release, May 7, 2004
- Copyright © 2004 ScoutNews, LLC. All rights reserved.
- This is a story from HealthDay, a service of ScoutNews, LLC.
Home | About Us | Contact Us | Site Index | Privacy Policy | Disclaimer | FOIA | Accessibility
Contact NWHIC
or call 1-800-994-WOMAN
NWHIC is a service of
the
U.S.
Department of Health and Human Services'
Office
on Women's Health